Phibro Animal Health | PAHC - Capital Ordinário





Capital Ordinário Alterar Data
Align Technology USD 71.75M 736K 2025-12
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Assertio Holdings USD 9K 0 2023-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Henry Schein USD 115.77M 2.8M 2025-12
Idexx Laboratories USD 79.85M 154K 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Pacira USD 41.12M 1.85M 2025-12
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Zoetis USD 424.93M 16.54M 2025-12